header-logo
Research Group Lab Hall
Pharmacology and Toxicology

Therapeutic Accelerator Program (TAP) at the Medical College of Wisconsin

The Therapeutic Accelerator Program (TAP) in the Department of Pharmacology & Toxicology serves MCW and Clinical & Translational Science Institute of Southeast Wisconsin partner institutions. The process of translating research ideas into technologies that improve human health is many steps and requires the assistance of different teams with diverse expertise. TAP catalyzes the bench to beside journey, bridging the gap between basic research and the development process. TAP provides advising, project-based funding opportunities, and connections to our network of resources to de-risk and advance technologies along the path to commercialization.

mcw-taps-program-logo

Services

  • Project-based funding opportunities for therapeutic development (Drugs, devices, diagnostics, platform technologies, HealthTech)
  • Expert advising
  • Therapeutic product development and entrepreneurship education

Therapeutic Accelerator Program (TAP) Pillars of Support

Teaching & Education

  • Modern Drug Discovery & Development course
  • Professional development course for trainees
  • Formal entrepreneurship and therapeutic product development education for faculty and trainees developing new technologies
  • Translational Workforce Development

Advising

  • Help investigators start the product development process and identify next critical steps
  • Facilitate internal and external collaborations
  • Concept validation and independent scientific review by panels of experts
  • Guide the scientific milestones of the development process and connect investigators to the business, legal, regulatory, and capital resources

Project Funding

  • Competitive project-based funding
  • $1.4M in funding support awarded by TAP
  • $8M awarded to projects by external sources
  • Executed 25 funded projects
  • 112 funding proposals received

Therapeutic Accelerator Program (TAP) Impact

  • 1 marketed product
  • 2 licensed technologies
  • 2 additional technologies in talks for licensing
  • 5 startup companies incorporated
  • 7 additional startup companies assisted
  • 9 patents awarded
  • 10 additional patents filed/pending
  • 4 new intellectual property disclosures
  • 2 clinical trials
  • Over 200 consultations

Contact Us

General inquiries and advising

Kristin Ciezki, PhD

Director, Therapeutic Accelerator Program

kciezki@mcw.edu | (414) 955-4605

 

Do you have an idea that you think might be patentable? Please reach out to MCW's Office of Technology Development at inventions@mcw.edu.

© 2025 Medical College of Wisconsin.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The Medical College of Wisconsin is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.